Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-01 Sale | 2024-03-05 8:08 pm | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 4,768 | $53.76 | $256,328 | 101,363 (Direct) | View |
| 2023-09-05 Sale | 2023-09-06 5:51 pm | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 6,000 | $37.96 | $227,760 | 51,281 (Direct) | View |
| 2023-06-19 Sale | 2023-06-21 6:17 pm | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 305 | $48.2 | $14,701 | 57,281 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 7:51 pm | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 3,664 | $45.25 | $165,796 | 96,744 (Direct) | View |
| 2022-06-19 Sale | 2022-06-22 7:27 pm | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 295 | $54.78 | $16,160 | 36,160 (Direct) | View |
| 2022-03-01 Sale | 2022-03-03 6:11 pm | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 2,713 | $66.62 | $180,740 | 61,217 (Direct) | View |
| 2021-10-14 Sale | 2021-10-18 6:58 pm | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 303 | $81.14 | $24,585 | 25,030 (Direct) | View |
| 2021-07-06 Sale | 2021-07-08 11:56 am | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 375 | $91.53 | $34,324 | 25,333 (Direct) | View |
| 2021-06-19 Sale | 2021-06-23 5:55 pm | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 1,009 | $94.82 | $95,670 | 25,708 (Direct) | View |
| 2021-05-06 Sale | 2021-05-10 6:10 pm | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 700 | $113.67 | $79,572 | 26,717 (Direct) | View |
| 2021-04-20 Sale | 2021-04-21 8:07 pm | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 396 | $104.28 | $41,295 | 27,417 (Direct) | View |
| 2021-03-01 Sale | 2021-03-03 8:42 pm | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 3,177 | $138.17 | $438,959 | 38,813 (Direct) | View |
| 2020-06-03 Sale | 2021-02-03 8:04 pm | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 2,516 | $74.69 | $187,920 | 20,854 (Direct) | View |
| 2020-10-14 Sale | 2020-10-16 7:20 pm | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 220 | $88 | $19,360 | 23,370 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-03 Option Award | 2024-10-07 4:37 pm | N/A 2034-10-02 | Inozyme Pharma Inc. | INZY | Harris Erik Director | 56,000 | $0 | 56,000 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 6:27 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | Harris Erik Director | 23,868 | $0 | 34,953 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:08 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 54,557 | $0 | 101,363 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 6:02 pm | N/A 2033-06-01 | Denali Therapeutics Inc. | DNLI | Harris Erik Director | 16,865 | $0 | 23,734 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 7:51 pm | N/A 2033-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 64,063 | $0 | 96,744 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 6:11 pm | N/A 2032-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 38,900 | $0 | 61,217 (Direct) | View |
| 2022-02-03 Option Award | 2022-02-07 6:54 pm | N/A 2032-02-03 | Denali Therapeutics Inc. | DNLI | Harris Erik Director | 27,476 | $0 | 27,476 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 8:42 pm | N/A 2031-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 21,136 | $0 | 38,813 (Direct) | View |
| 2020-07-06 Tax Withholding | 2020-07-08 12:29 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 260 | $86.75 | 23,590 (Direct) | View |
| 2020-06-19 Tax Withholding | 2020-06-22 1:47 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 303 | $78.22 | 23,850 (Direct) | View |
| 2020-05-06 Tax Withholding | 2020-05-08 8:11 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 209 | $66.26 | 24,153 (Direct) | View |
| 2020-04-19 Tax Withholding | 2020-04-21 3:31 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 210 | $58.57 | 24,362 (Direct) | View |
| 2020-03-01 Option Award | 2020-03-03 8:02 pm | N/A 2030-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 33,087 | $0 | 46,572 (Direct) | View |
| 2020-03-01 Tax Withholding | 2020-03-03 8:02 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 824 | $56.08 | 46,572 (Direct) | View |